When you purchase and use a consumer product, you trust that it is safe enough for you and your family. You trust that the product designer and manufacturer produced a product that will not injure someone. Sometimes that trust is not warranted.
Seemingly safe products may be extremely dangerous. At Baggett, McCall, Burgess, Watson & Gaughan, LLC, we offer experienced and aggressive legal advocacy to protect the rights of clients who have suffered as a result of dangerous or defective products.
Dangerous or defective products can cause serious injury or wrongful death. When you or someone you love has been hurt, please contact us as soon as possible for an initial consultation and case evaluation.
Manufacturers have a responsibility to ensure that their products are safe for consumer use. Defective products can be dangerous, and if a person is injured while using a product, the manufacturer can be held legally liable. In some cases, sellers, wholesalers, designers and parts manufacturers may also bear responsibility.
Manufacturers must inform consumers of any dangers inherent in the use of their products.
They must be certain not to include substandard or malfunctioning parts in the products they make.
If a product is known to be dangerous or cause injury, a recall must be made to protect consumers.
We have experience in cases involving design defects, manufacturing defects, and failure to warn of dangerous products. Our products liability attorneys will begin an immediate investigation to preserve all necessary evidence for your case.
Ketoacidosis (Excessive Blood Acid Levels) Arising from Type 2 Diabetes Medications
The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines canagliflozin, dapagliflozin, and empagliflozin, all of which are SGLT2 Inhibitors, may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization. The FDA issued the warning after receiving reports of a number of cases of acidosis reported as diabetic ketoacidosis (DKA), ketoacidosis, or ketosis in patients treated with SGLT2 inhibitors in 2013 and 2014. All patients required emergency room visits or hospitalization to treat the ketoacidosis. The FDA has continued to receive additional reports for DKA and ketoacidosis in patients treated with SGLT2 inhibitors.
Patients should pay close attention to any signs of ketoacidosis and seek medical attention immediately if they experience symptoms such as difficulty breathing, nausea, vomiting, abdominal pain, confusion, and unusual fatigue or sleepiness. Do not stop or change your diabetes medicines without first talking to your doctor. Healthcare professionals should evaluate for the presence of acidosis, including ketoacidosis, in patients experiencing these signs or symptoms; discontinue SGLT2 inhibitors if acidosis is confirmed, and take appropriate measures to correct the acidosis and monitor sugar levels.
SGLT2 inhibitors are a class of prescription medicines that are FDA-approved for use with diet and exercise to lower blood sugar in adults with type 2 diabetes. When untreated, type 2 diabetes can lead to serious problems, including blindness, nerve and kidney damage, and heart disease. SGLT2 inhibitors lower blood sugar by causing the kidneys to remove sugar from the body through the urine.
Products liability in Louisiana
Following tort reforms in 1990, products liability claims in Louisiana are no longer a matter of strict liability. Cases are more difficult to prove as the law does not offer the same protections to consumers. If you or someone you love has suffered a product-related injury, it is important to consult with experienced defective product attorneys who can protect your rights against a negligent manufacturer. Our attorneys know how to identify all responsible parties and aggressively pursue maximum compensation on your behalf.